103 related articles for article (PubMed ID: 15212824)
1. Early complement activation increases in the brain in some aged normal subjects.
Loeffler DA; Camp DM; Schonberger MB; Singer DJ; LeWitt PA
Neurobiol Aging; 2004 Sep; 25(8):1001-7. PubMed ID: 15212824
[TBL] [Abstract][Full Text] [Related]
2. Up-regulated production and activation of the complement system in Alzheimer's disease brain.
Yasojima K; Schwab C; McGeer EG; McGeer PL
Am J Pathol; 1999 Mar; 154(3):927-36. PubMed ID: 10079271
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical appearance of complement protein, C4d, in the nervous system and its significance].
Yamada T
No To Shinkei; 1998 Feb; 50(2):137-45. PubMed ID: 9513203
[No Abstract] [Full Text] [Related]
4. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
[TBL] [Abstract][Full Text] [Related]
5. Expression of cortical and hippocampal apoptosis-inducing factor (AIF) in aging and Alzheimer's disease.
Reix S; Mechawar N; Susin SA; Quirion R; Krantic S
Neurobiol Aging; 2007 Mar; 28(3):351-6. PubMed ID: 16504343
[TBL] [Abstract][Full Text] [Related]
6. [Brain volume changes of patients with Alzheimer's disease in two years: a case control study].
Wang T; Xiao SF; Li X; Zhu MJ; Hao J; Ding B; Ling HW; Chen KM
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1027-31. PubMed ID: 18754434
[TBL] [Abstract][Full Text] [Related]
7. Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment.
Jauhiainen AM; Pihlajamäki M; Tervo S; Niskanen E; Tanila H; Hänninen T; Vanninen RL; Soininen H
Hippocampus; 2009 Feb; 19(2):166-75. PubMed ID: 18777563
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.
Hellström-Lindahl E; Ravid R; Nordberg A
Neurobiol Aging; 2008 Feb; 29(2):210-21. PubMed ID: 17098332
[TBL] [Abstract][Full Text] [Related]
9. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of COX-2 in subdivisions of the hippocampus during aging and in Alzheimer's disease: the Hisayama Study.
Fujimi K; Noda K; Sasaki K; Wakisaka Y; Tanizaki Y; Iida M; Kiyohara Y; Kanba S; Iwaki T
Dement Geriatr Cogn Disord; 2007; 23(6):423-31. PubMed ID: 17457030
[TBL] [Abstract][Full Text] [Related]
11. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
[TBL] [Abstract][Full Text] [Related]
12. Complement activated C4d immunoreactive oligodendrocytes delineate small cortical plaques in multiple sclerosis.
Schwab C; McGeer PL
Exp Neurol; 2002 Mar; 174(1):81-8. PubMed ID: 11869036
[TBL] [Abstract][Full Text] [Related]
13. Early involvement of small inhibitory cortical interneurons in Alzheimer's disease.
Koliatsos VE; Kecojevic A; Troncoso JC; Gastard MC; Bennett DA; Schneider JA
Acta Neuropathol; 2006 Aug; 112(2):147-62. PubMed ID: 16758165
[TBL] [Abstract][Full Text] [Related]
14. Levels of complement components iC3b, C3c, C4, and SC5b-9 in peritoneal fluid and serum of infertile women with endometriosis.
Kabut J; Kondera-Anasz Z; Sikora J; Mielczarek-Palacz A
Fertil Steril; 2007 Nov; 88(5):1298-303. PubMed ID: 17482181
[TBL] [Abstract][Full Text] [Related]
15. Immune blood biomarkers of Alzheimer disease patients.
Avagyan H; Goldenson B; Tse E; Masoumi A; Porter V; Wiedau-Pazos M; Sayre J; Ong R; Mahanian M; Koo P; Bae S; Micic M; Liu PT; Rosenthal MJ; Fiala M
J Neuroimmunol; 2009 May; 210(1-2):67-72. PubMed ID: 19329192
[TBL] [Abstract][Full Text] [Related]
16. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
[TBL] [Abstract][Full Text] [Related]
17. Prepulse inhibition in patients with Alzheimer's disease.
Hejl AM; Glenthøj B; Mackeprang T; Hemmingsen R; Waldemar G
Neurobiol Aging; 2004 Sep; 25(8):1045-50. PubMed ID: 15212829
[TBL] [Abstract][Full Text] [Related]
18. Peripheral insulin and brain structure in early Alzheimer disease.
Burns JM; Donnelly JE; Anderson HS; Mayo MS; Spencer-Gardner L; Thomas G; Cronk BB; Haddad Z; Klima D; Hansen D; Brooks WM
Neurology; 2007 Sep; 69(11):1094-104. PubMed ID: 17846409
[TBL] [Abstract][Full Text] [Related]
19. C4b-binding protein in Alzheimer's disease: binding to Abeta1-42 and to dead cells.
Trouw LA; Nielsen HM; Minthon L; Londos E; Landberg G; Veerhuis R; Janciauskiene S; Blom AM
Mol Immunol; 2008 Aug; 45(13):3649-60. PubMed ID: 18556068
[TBL] [Abstract][Full Text] [Related]
20. Density of Sgt1-immunopositive neurons is decreased in the cerebral cortex of Alzheimer's disease brain.
Spiechowicz M; Bernstein HG; Dobrowolny H; Leśniak W; Mawrin C; Bogerts B; Kuźnicki J; Filipek A
Neurochem Int; 2006 Oct; 49(5):487-93. PubMed ID: 16698122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
